1-855-378-42281-855-378-4228
One of the out-patient rehabilitation options for people in Barrington struggling with opioid dependence and addiction is opioid maintenance therapy. Licensed facilities and doctors are authorized to dispense specific medications to opioid addicted individuals, many of which are opioids themselves and are habit forming. In low enough doses the user does not experience being high and also doesn't have severe cravings and isn't in opioid withdrawal. Methadone is the first drug administered for this reason, but there are alternative choices to select from.
Methadone is an opiate and can be taken at an out-patient clinic licensed to dispense the med, that is taken on a daily basis as a pill or liquid. The cost of the drug is around $150 monthly. Buprenorphine is also an opioid-based drug, and is in pill form often taken every other day. But unlike Methadone that can only be dispensed in highly well-regulated medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is about just under $300 a month for the generic version of the med. There is also a type of buprenorphine that contains naloxone, that is a drug which blocks the effects of opiates. An individual taking this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken daily, and is priced about $450 a month. Naltrexone is another med used in opioid maintenance therapy, but unlike the other drugs mentioned here it is an opiate blocker and isn't an opiate. There is an option to take this drug as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents someone from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 monthly.
There are 1 Drug and Alcohol Treatment Programs offering this service in Barrington, RI
For All Drug and Alcohol Rehab Facilities In Barrington, Click Here.
